These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18041036)

  • 1. Porous silicon surfaces: a candidate substrate for reverse protein arrays in cancer biomarker detection.
    Ressine A; Corin I; Järås K; Guanti G; Simone C; Marko-Varga G; Laurell T
    Electrophoresis; 2007 Dec; 28(23):4407-15. PubMed ID: 18041036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macro-/nanoporous silicon as a support for high-performance protein microarrays.
    Ressine A; Ekström S; Marko-Varga G; Laurell T
    Anal Chem; 2003 Dec; 75(24):6968-74. PubMed ID: 14670060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective.
    Järås K; Ressine A; Nilsson E; Malm J; Marko-Varga G; Lilja H; Laurell T
    Anal Chem; 2007 Aug; 79(15):5817-25. PubMed ID: 17605470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of surfaces for antibody microarrays: design of macroporous silicon substrates.
    Steinhauer C; Ressine A; Marko-Varga G; Laurell T; Borrebaeck CA; Wingren C
    Anal Biochem; 2005 Jun; 341(2):204-13. PubMed ID: 15907865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
    Liu C; Guo J; Qu L; Bing D; Meng L; Wu J; Shou C
    Cancer Lett; 2008 Sep; 269(1):148-58. PubMed ID: 18586385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
    Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porous silicon protein microarray technology and ultra-/superhydrophobic states for improved bioanalytical readout.
    Ressine A; Marko-Varga G; Laurell T
    Biotechnol Annu Rev; 2007; 13():149-200. PubMed ID: 17875477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust estimation of protein expression ratios with lysate microarray technology.
    Mircean C; Shmulevich I; Cogdell D; Choi W; Jia Y; Tabus I; Hamilton SR; Zhang W
    Bioinformatics; 2005 May; 21(9):1935-42. PubMed ID: 15647295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of porous silicon substrate for well-characterised sensitive DNA chip implement.
    Bessueille F; Dugas V; Vikulov V; Cloarec JP; Souteyrand E; Martin JR
    Biosens Bioelectron; 2005 Dec; 21(6):908-16. PubMed ID: 16257660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using continuous porous silicon gradients to study the influence of surface topography on the behaviour of neuroblastoma cells.
    Khung YL; Barritt G; Voelcker NH
    Exp Cell Res; 2008 Feb; 314(4):789-800. PubMed ID: 18054914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attachment and response of human fibroblast and breast cancer cells to three dimensional silicon microstructures of different geometries.
    Nikkhah M; Strobl JS; Agah M
    Biomed Microdevices; 2009 Apr; 11(2):429-41. PubMed ID: 19058013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer.
    Alvarez-Chaver P; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; Páez de la Cadena M
    Int J Biochem Cell Biol; 2007; 39(3):529-40. PubMed ID: 17084656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling.
    Alfonso P; Cañamero M; Fernández-Carbonié F; Núñez A; Casal JI
    J Proteome Res; 2008 Oct; 7(10):4247-55. PubMed ID: 18707159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.